Get what you need from the world’s largest portfolio of nuclear receptors.

INDIGO have the largest portfolio of cell-based nuclear receptor assays in the world, helping you identify compounds with the highest selectivity and the lowest potential for unwanted effects and off-target responses. Our broad portfolio of nuclear receivers makes us the preferred source for single receiver or entire panel experiments.

Make confident decisions with clear results on your compounds

To empower confident decision-making throughout the drug discovery process, INDIGO technology generates clear single receptor or full panel detection results, allowing for better interpretation and more accurate data. Using a luminescence-based method and our proprietary CryoMite ™ preservation process, we provide reproducible results on the efficacy, potency, and selectivity of chemicals, as well as comprehensive lab reports that include charts, summaries, and helpful information.

Portfolio Products

• The largest catalog of tests for nuclear receptors
• Clear and reproducible results for in vitro toxicology experiments and nuclear receptors
• INDIGlo Luciferase Detection Reagent